Aarti Drugs nears 5-year high; stock rallies 26% in 5 days in a weak market

Analysts believe the firm's API business will continue its growth momentum driven by capacity expansion and gain in market share in existing products

Analysts believe the firm's API business will continue its growth momentum driven by capacity expansion and gain in market share in existing products https://ift.tt/32vHIMR February 26, 2020 at 07:17PM